The Notice of Allowance for the patent application indicates that Nuwellis is likely to secure a patent for its blood filtration system. This development could strengthen its product portfolio and market position in the healthcare sector, particularly in treating congestive heart failure, potentially leading to positive investor sentiment and a short-term stock price increase.